DE726075T1 - Nicht-inorganische pharmazeutische salzige Lösungen zur endonasale Verabreichung - Google Patents

Nicht-inorganische pharmazeutische salzige Lösungen zur endonasale Verabreichung

Info

Publication number: DE726075T1
Authority: DE; Germany
Prior art keywords: saline solutions; endonasal administration; inorganic pharmaceutical; endonasal; pharmaceutical saline
Prior art date: 1995-02-08
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

DE0726075T

Other languages

English (en)

Inventor

Paolo Alberto Veronesi

Emanuela Peschechera

Anna Maria Veronesi

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Therapicon SRL

Original Assignee

Therapicon SRL

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-02-08

Filing date

1995-02-08

Publication date

1996-12-12

1995-02-08 Application filed by Therapicon SRL filed Critical Therapicon SRL

1996-12-12 Publication of DE726075T1 publication Critical patent/DE726075T1/de

Status Pending legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/585—Calcitonins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Physical Education & Sports Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Endocrinology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Orthopedic Medicine & Surgery (AREA)
Dermatology (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Toxicology (AREA)
Otolaryngology (AREA)
Biochemistry (AREA)
Rheumatology (AREA)
Obesity (AREA)
Hematology (AREA)
Diabetes (AREA)
Immunology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

DE0726075T 1995-02-08 1995-02-08 Nicht-inorganische pharmazeutische salzige Lösungen zur endonasale Verabreichung Pending DE726075T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP95101681A EP0726075A1 (de)	1995-02-08	1995-02-08	Nicht-inorganische pharmazeutische salzige Lösungen zur endonasale Verabreichung

Publications (1)

Publication Number	Publication Date
DE726075T1 true DE726075T1 (de)	1996-12-12

Family

ID=8218965

Family Applications (4)

Application Number	Title	Priority Date	Filing Date
DE0726075T Pending DE726075T1 (de)	1995-02-08	1995-02-08	Nicht-inorganische pharmazeutische salzige Lösungen zur endonasale Verabreichung
DE69607749T Expired - Fee Related DE69607749T2 (de)	1995-02-08	1996-02-02	Analoge des calcitonin aus lachs, ihre herstellung und ihre verwendung als medizin und als analytische reagentien
DE29622959U Expired - Lifetime DE29622959U1 (de)	1995-02-08	1996-02-02	Analoge des Lachs-Calcitonin
DE69620393T Expired - Lifetime DE69620393T2 (de)	1995-02-08	1996-02-08	PHARMAZEUTISCHE NICHTINORGANISCHE SALZLÖSUNGEN FÜR ENDONASALE VERABREICHUNG EINEs CALCITONINs

Family Applications After (3)

Application Number	Title	Priority Date	Filing Date
DE69607749T Expired - Fee Related DE69607749T2 (de)	1995-02-08	1996-02-02	Analoge des calcitonin aus lachs, ihre herstellung und ihre verwendung als medizin und als analytische reagentien
DE29622959U Expired - Lifetime DE29622959U1 (de)	1995-02-08	1996-02-02	Analoge des Lachs-Calcitonin
DE69620393T Expired - Lifetime DE69620393T2 (de)	1995-02-08	1996-02-08	PHARMAZEUTISCHE NICHTINORGANISCHE SALZLÖSUNGEN FÜR ENDONASALE VERABREICHUNG EINEs CALCITONINs

Country Status (17)

Country	Link
US (2)	US6087338A (de)
EP (3)	EP0726075A1 (de)
JP (2)	JPH11506416A (de)
KR (2)	KR100430101B1 (de)
AT (2)	ATE191719T1 (de)
AU (2)	AU4787996A (de)
BR (1)	BR9607410A (de)
CA (2)	CA2210664A1 (de)
DE (4)	DE726075T1 (de)
ES (2)	ES2146869T3 (de)
GB (1)	GB9523442D0 (de)
HU (1)	HUP9600266A3 (de)
PE (1)	PE28397A1 (de)
PL (1)	PL183398B1 (de)
PT (2)	PT809654E (de)
WO (2)	WO1996024618A1 (de)
ZA (2)	ZA96779B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0726075A1 (de) *	1995-02-08	1996-08-14	Therapicon Srl	Nicht-inorganische pharmazeutische salzige Lösungen zur endonasale Verabreichung
US6034064A (en) *	1995-04-07	2000-03-07	Hoechst Pharmaceuticals & Chemicals K.K.	Peptides and therapeutic agent for autoimmune diseases containing the same
DE19653969A1 (de) *	1996-12-20	1998-06-25	Boehringer Ingelheim Kg	Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
IT1298780B1 (it) *	1998-03-24	2000-02-02	Therapicon Srl	Preparazioni parenterali a base di calcitonina
US6734162B2 (en)	2000-01-24	2004-05-11	Minimed Inc.	Mixed buffer system for stabilizing polypeptide formulations
AU783952B2 (en) *	2000-02-04	2006-01-05	Unigene Laboratories, Inc.	Nasal calcitonin formulations
DE10024451A1 (de) *	2000-05-18	2001-11-29	Asta Medica Ag	Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung
US6737401B2 (en)	2001-06-28	2004-05-18	Metronic Minimed, Inc.	Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom
JP4225416B2 (ja) *	2001-06-29	2009-02-18	旭化成ファーマ株式会社	タンパク質製剤の安定性を改善する方法
US20090035260A1 (en) *	2002-07-29	2009-02-05	Therapicon Srl	Enhanced nasal composition of active peptide
ITMI20021684A1 (it) *	2002-07-29	2004-01-29	Therapicon Srl	Composizione farmaceutica di peptide nasale
US7812120B2 (en) *	2003-03-21	2010-10-12	Par Pharmaceutical, Inc.	Nasal calcitonin formulations containing chlorobutanol
ITMI20040235A1 (it) *	2004-02-13	2004-05-13	Therapicon Srl	Preparazione farmaceutica per il cavo orale
GB0422644D0 (en) *	2004-10-12	2004-11-10	Novartis Ag	Organic compounds
TW200722518A (en)	2005-03-31	2007-06-16	Chugai Pharmaceutical Co Ltd	Sc(fv)2 structural isomers
US9241994B2 (en)	2005-06-10	2016-01-26	Chugai Seiyaku Kabushiki Kaisha	Pharmaceutical compositions containing sc(Fv)2
AU2006256041B2 (en) *	2005-06-10	2012-03-29	Chugai Seiyaku Kabushiki Kaisha	Stabilizer for protein preparation comprising meglumine and use thereof
CN100349611C (zh) *	2005-11-25	2007-11-21	中国药科大学	鲑降钙素吸入粉雾剂及其制备方法
AU2010206614B2 (en) *	2009-01-22	2015-03-26	Keybioscience Ag	Treatment for obesity
US9533022B2 (en)	2011-11-02	2017-01-03	KeyBioscience A/S	Peptide analogs for treating diseases and disorders
US9006172B2 (en)	2011-11-02	2015-04-14	Keybioscience Ag	Peptide analogs for treating diseases and disorders

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3926938A (en) *	1974-08-12	1975-12-16	Armour Pharma	Synthesis of salmon calcitonin
US4217268A (en) *	1978-07-20	1980-08-12	Hughes John L	Synthesis of peptides
CH657779A5 (de) *	1982-10-05	1986-09-30	Sandoz Ag	Galenische zusammensetzungen enthaltend calcitonin.
GB2127689B (en) *	1982-10-05	1986-07-09	Sandoz Ltd	Calcitonin inhalation compositions
JPS59163313A (ja) *	1983-03-09	1984-09-14	Teijin Ltd	経鼻投与用ペプチドホルモン類組成物
US4659804A (en) *	1984-11-01	1987-04-21	Armour Pharmaceutical Company	(Bis-1,7-S-acetamidomethyl-L-cysteine)salmon calcitonin
JPS61267528A (ja) *	1984-11-26	1986-11-27	Yamanouchi Pharmaceut Co Ltd	吸収促進剤を含有するカルシトニン経鼻剤
US4622386A (en) *	1985-03-28	1986-11-11	Armour Pharmaceutical Company	[1,7-di-alanine]calcitonin
US4639510A (en) *	1985-10-04	1987-01-27	Armour Pharmaceutical Company	(1-S-acetamidomethyl cysteine, 7-alanine)calcitonin
HUT44794A (en) *	1985-12-04	1988-04-28	Sandoz Ag	Process for production of calcitonine-derivatives and medical preparatives containing such compounds
ES2052642T3 (es) *	1987-07-08	1994-07-16	Mitsubishi Petrochemical Co	Nuevo derivado de calcitonina y su sal.
US5059587A (en) *	1987-08-03	1991-10-22	Toyo Jozo Company, Ltd.	Physiologically active peptide composition for nasal administration
EP0327756B1 (de) *	1987-11-13	1994-01-26	Smithkline Beecham Farmaceutici S.p.A.	Ein Calcitonin sowie ein Glycyrrhizinat als Absorptionsförderer enthaltende Arzneimittel
AU629552B2 (en) *	1988-06-16	1992-10-08	Teijin Limited	S-sulfonated calcitonin derivatives
JPH0694851B2 (ja) *	1988-06-27	1994-11-24	株式会社日立製作所	蒸発燃料制御装置
US5026825A (en) *	1988-09-08	1991-06-25	Rhone-Poulenc Rorer Pharmaceuticals Inc.	Intranasal calcitonin formulations
JPH02104531A (ja) *	1988-10-14	1990-04-17	Toyo Jozo Co Ltd	経鼻投与用生理活性ペプチド組成物
JPH0643339B2 (ja) *	1990-05-25	1994-06-08	旭化成工業株式会社	カルシトニン類水溶液組成物の安定化法
IT1248725B (it) *	1990-06-12	1995-01-26	Sclavo Spa	Composizione farmaceutica in polvere per somministrazione per via nasale contenente essenzialmente calcitonina ed un eccipiente idrosolubile
JPH078806B2 (ja) *	1990-08-16	1995-02-01	旭化成工業株式会社	カルシトニン類含有経鼻投与用乳剤
JP3179538B2 (ja) *	1990-12-11	2001-06-25	ノバルティスアクチエンゲゼルシャフト	安定なヒトカルシトニンの水性溶液
IT1244500B (it) *	1991-03-21	1994-07-15	Pulitzer Italiana	Impiego di sali minerali di trometamina in composizioni farmaceutiche a base di calcitonina somministrabili per via rettale in terapia umana
IT1251685B (it) *	1991-10-11	1995-05-19	Isf Spa	Composizioni farmaceutiche contenenti una calcitonina
US5571788A (en) *	1991-12-09	1996-11-05	Ciba-Geigy Corporation	Stable calcitonin pharmaceutical compositions
IT1255895B (it) *	1992-10-20	1995-11-17	Laura Chiodini	Composizioni farmaceutiche contenenti una calcitonina
EP0726075A1 (de) *	1995-02-08	1996-08-14	Therapicon Srl	Nicht-inorganische pharmazeutische salzige Lösungen zur endonasale Verabreichung

1995
- 1995-02-08 EP EP95101681A patent/EP0726075A1/de not_active Withdrawn
- 1995-02-08 DE DE0726075T patent/DE726075T1/de active Pending
- 1995-11-15 GB GBGB9523442.3A patent/GB9523442D0/en active Pending
1996
- 1996-02-01 ZA ZA96779A patent/ZA96779B/xx unknown
- 1996-02-02 KR KR1019970705486A patent/KR100430101B1/ko not_active IP Right Cessation
- 1996-02-02 AT AT96903997T patent/ATE191719T1/de not_active IP Right Cessation
- 1996-02-02 DE DE69607749T patent/DE69607749T2/de not_active Expired - Fee Related
- 1996-02-02 ES ES96903997T patent/ES2146869T3/es not_active Expired - Lifetime
- 1996-02-02 CA CA002210664A patent/CA2210664A1/en not_active Abandoned
- 1996-02-02 ZA ZA96835A patent/ZA96835B/xx unknown
- 1996-02-02 JP JP8523975A patent/JPH11506416A/ja not_active Ceased
- 1996-02-02 AU AU47879/96A patent/AU4787996A/en not_active Abandoned
- 1996-02-02 PT PT96903997T patent/PT809654E/pt unknown
- 1996-02-02 WO PCT/EP1996/000487 patent/WO1996024618A1/en active IP Right Grant
- 1996-02-02 EP EP96903997A patent/EP0809654B1/de not_active Expired - Lifetime
- 1996-02-02 DE DE29622959U patent/DE29622959U1/de not_active Expired - Lifetime
- 1996-02-05 KR KR1019960002720A patent/KR100397034B1/ko not_active IP Right Cessation
- 1996-02-07 PL PL96312683A patent/PL183398B1/pl not_active IP Right Cessation
- 1996-02-07 JP JP02092496A patent/JP4123309B2/ja not_active Expired - Fee Related
- 1996-02-07 HU HU9600266A patent/HUP9600266A3/hu unknown
- 1996-02-08 EP EP96903969A patent/EP0809512B1/de not_active Expired - Lifetime
- 1996-02-08 ES ES96903969T patent/ES2173267T3/es not_active Expired - Lifetime
- 1996-02-08 BR BR9607410A patent/BR9607410A/pt not_active IP Right Cessation
- 1996-02-08 AT AT96903969T patent/ATE215381T1/de not_active IP Right Cessation
- 1996-02-08 CA CA002212520A patent/CA2212520A1/en not_active Abandoned
- 1996-02-08 AU AU47863/96A patent/AU4786396A/en not_active Abandoned
- 1996-02-08 WO PCT/EP1996/000446 patent/WO1996024370A1/en active IP Right Grant
- 1996-02-08 PE PE1996000091A patent/PE28397A1/es not_active Application Discontinuation
- 1996-02-08 PT PT96903969T patent/PT809512E/pt unknown
- 1996-02-08 DE DE69620393T patent/DE69620393T2/de not_active Expired - Lifetime
1997
- 1997-08-08 US US08/908,986 patent/US6087338A/en not_active Expired - Fee Related
- 1997-08-08 US US08/907,602 patent/US6107277A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
HUP9600266A3 (en)	2000-09-28
KR960030948A (ko)	1996-09-17
DE29622959U1 (de)	1998-03-05
EP0809654A1 (de)	1997-12-03
EP0726075A1 (de)	1996-08-14
HU9600266D0 (en)	1996-04-29
CA2212520A1 (en)	1996-08-15
EP0809512B1 (de)	2002-04-03
BR9607410A (pt)	1998-07-07
JPH11506416A (ja)	1999-06-08
ES2173267T3 (es)	2002-10-16
JPH08245417A (ja)	1996-09-24
PT809512E (pt)	2002-09-30
ATE191719T1 (de)	2000-04-15
JP4123309B2 (ja)	2008-07-23
EP0809654B1 (de)	2000-04-12
AU4787996A (en)	1996-08-27
DE69620393D1 (de)	2002-05-08
ES2146869T3 (es)	2000-08-16
CA2210664A1 (en)	1996-08-15
KR19980702091A (ko)	1998-07-15
DE69607749D1 (de)	2000-05-18
PL312683A1 (en)	1996-08-19
WO1996024370A1 (en)	1996-08-15
GB9523442D0 (en)	1996-01-17
PE28397A1 (es)	1997-08-22
US6107277A (en)	2000-08-22
KR100430101B1 (ko)	2006-02-13
DE69607749T2 (de)	2000-07-27
ATE215381T1 (de)	2002-04-15
KR100397034B1 (ko)	2003-11-13
ZA96835B (en)	1996-08-19
EP0809512A1 (de)	1997-12-03
ZA96779B (en)	1996-08-29
HUP9600266A2 (en)	1997-06-30
AU4786396A (en)	1996-08-27
PL183398B1 (pl)	2002-06-28
DE69620393T2 (de)	2003-01-16
US6087338A (en)	2000-07-11
PT809654E (pt)	2000-10-31
WO1996024618A1 (en)	1996-08-15

Publication	Publication Date	Title
DE726075T1 (de)	1996-12-12	Nicht-inorganische pharmazeutische salzige Lösungen zur endonasale Verabreichung
ES2569949T3 (es)	2016-05-13	Formulaciones farmacéuticas que comprenden un péptido complejado con una dicetopiperazina
ATE217188T1 (de)	2002-05-15	Granulierte pharmazeutische zusammensetzung
DK0416951T3 (da)	1994-02-14	Lægemidler indeholdende salmeterol og fluticason
WO1996024370B1 (en)	1996-09-19	Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin
DE69434418D1 (de)	2005-08-04	Orale Dareichungsform
CY1105707T1 (el)	2010-12-22	Συνδυασμοι φορμοτερολης και ενος αλατος τριοτροπιου
ATE235895T1 (de)	2003-04-15	Arzneistoff-abgabesystem enthaltend eine festgepackte, feste arzneistoffbasis
CA2288143A1 (en)	1998-11-05	Activated protein c formulations
BR9106114A (pt)	1993-03-09	Metodo para tratar ou prevenir uma doenca auto-imune (ad) e formulacao farmaceutica
NO941276D0 (no)	1994-04-08	Lipofile, oligosakkaride antibiotikasaltpreparater
DE69002718D1 (de)	1993-09-16	Medikamente.
ATE12649T1 (de)	1985-04-15	Optisch aktives dipeptide, seine pharmazeutisch vertraeglichen salze, verfahren zur herstellung und diese enthaltende pharmazeutische praeparate.
IL110888A0 (en)	1994-11-28	Pharmaceutical compositions for the treatment of liver diseases comprising a benzothiazepine derivative
ATE15139T1 (de)	1985-09-15	Phosphonomycine pharmazeutische zusammensetzung in tablettenform.
TH43276A (de)	2001-02-23
MX9605633A (es)	1998-05-31	Composicion farmaceutica, metodo y dispositivo para prevenir o tratar resequedad de los ojos o enfermedad ocasionada por la misma.
AR002040A1 (es)	1998-01-07	Soluciones farmacéuticas salinas no inorgánicas para administración endonasal conteniendo una calcitonina natural o modificada y excipientes orgánicos.